The DOI matches its Crossref record; 23 of the 27 references it cites were found in a registry or an index.
Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak
Open accessAbstract
Abstract The novel COVID-19 outbreak has affected more than 200 countries and territories as of March 2020. Given that patients with cancer are generally more vulnerable to infections, systematic analysis of diverse cohorts of patients with cancer affected by COVID-19 is needed. We performed a multicenter study including 105 patients with cancer and 536 age-matched noncancer patients confirmed with COVID-19. Our results showed COVID-19 patients with cancer had higher risks in all severe outcomes. Patients with hematologic cancer, lung cancer, or with metastatic cancer (stage IV) had the highest frequency of severe events. Patients with nonmetastatic cancer experienced similar frequencies of severe conditions to those observed in patients without cancer. Patients who received surgery had higher risks of having severe events, whereas patients who underwent only radiotherapy did not demonstrate significant differences in severe events when compared with patients without cancer. These findings indicate that patients with cancer appear more vulnerable to SARS-CoV-2 outbreak. Significance: Because this is the first large cohort study on this topic, our report will provide much-needed information that will benefit patients with cancer globally. As such, we believe it is extremely important that our study be disseminated widely to alert clinicians and patients. This article is highlighted in the In This Issue feature, p. 747
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“They are among the vulnerable groups because they are at higher risk of being infected and showing more severe symptoms and even death when infected.[13]”
From Psychological Distress of Breast Cancer Survivors During the COVID-19 Pandemic and Related Factors: A Controlled Study. (2023) · cites this paper as [13]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Self-citationChen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Self-citationCancer statistics in China, 2015
Chen, W., Zheng, R., Baade, P. D., Zhang, S., Zeng, H., Bray, F., Jemal, A., Yu, X. Q., & He, J. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21338 · Cited by 17,038
Wu, Z., & McGoogan, J. M. (2020) · JAMA · doi:10.1001/jama.2020.2648 · Cited by 17,016
Yang, X., Yu, Y., Xu, J., Shu, H., Xia, J., Liu, H., Wu, Y., Zhang, L., Yu, Z., Fang, M., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30079-5 · Cited by 10,066
Self-citationPathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China
Liang, W., Guan, W., Chen, R., Wang, W., Li, J., Xu, K., Li, C., Ai, Q., Lu, W., Liang, H., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30096-6 · Cited by 4,384
Raje, N. S., & Anderson, K. C. (2000) · Current Treatment Options in Oncology · doi:10.1007/s11864-000-0017-x · Cited by 2,164
Clinical evidence does not support corticosteroid treatment for 2019-nCoV lung injury
Russell, C. D., Millar, J. E., & Baillie, J. K. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30317-2 · Cited by 2,040
Cited by
Sorted by citations
Items 401–500 of 1,001
Guarnera, A., Santini, E., & Podda, P. (2022) · Tomography · doi:10.3390/tomography8010041 · Cited by 19
Cancer immunotherapy does not increase the risk of death by COVID-19 in melanoma patientsPreprint
González‐Cao, M., Antonazas-Basa, M., Puértolas, T., Muñoz‐Couselo, E., Manzano, J. L., Carrera, C., Márquez‐Rodas, I., Criado, P. L., Rodríguez-Moreno, J. F., García‐Castaño, A., et al. (2020) · medRxiv · doi:10.1101/2020.05.19.20106971 · Cited by 18
Nichetti, F., Bini, M., Ambrosini, M., Ottini, A., Rametta, A., Leporati, R., Polastri, D., Pircher, C. C., Dotti, K. F., Ferrari, L., et al. (2020) · ESMO Open · doi:10.1136/esmoopen-2020-000883 · Cited by 18
Tabrizi, S., Trippa, L., Cagney, D. N., Tanguturi, S. K., Ventz, S., Fell, G. G., Wen, P. Y., Alexander, B. M., & Rahman, R. M. (2020) · Neuro-Oncology · doi:10.1093/neuonc/noaa111 · Cited by 17
Cancer and Immune Checkpoint Inhibitor Treatment in the Era of SARS-CoV-2 Infection
Gambichler, T., Reuther, J., Scheel, C., Susok, L., Kern, P., & Becker, J. C. (2020) · Cancers · doi:10.3390/cancers12113383 · Cited by 19
Adelhoefer, S. J., Berning, P., Solomon, S. B., Maybody, M., Whelton, S. P., Blaha, M. J., & Dzaye, O. D. A. (2021) · Cancer Causes & Control · doi:10.1007/s10552-021-01409-1 · Cited by 17
Ullah, A. Z. M. D., Sivapalan, L., Kocher, H. M., & Chelala, C. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-045077 · Cited by 17
Switzer, B., Haanen, J. B. A. G., Lorigan, P. C., Puzanov, I. J., & Turajlic, S. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002835 · Cited by 17
Seneviratne, S. L., Wijerathne, W., Yasawardene, P. C., & Somawardana, B. (2022) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/trac015 · Cited by 18
Wu, Q., Luo, S., & Xie, X. (2022) · BMC Cancer · doi:10.1186/s12885-022-09320-x · Cited by 17
Wang, X., Li, M., Shi, Q., Ji, H., Kong, S., Zhu, L., & Zhang, H. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.880978 · Cited by 17
Association between allergic conditions and COVID-19 susceptibility and outcomes
Chen, C., Song, X., Murdock, D. J., Marcus, A. F., Hussein, M. A., Jalbert, J. J., & Geba, G. P. (2024) · Annals of Allergy Asthma & Immunology · doi:10.1016/j.anai.2024.01.011 · Cited by 17
Self-citationImmunologic characterization of COVID-19 patients with hematological cancer
Maia, C., Martín‐Sánchez, E., Garcés, J., Cerio, A. L.-D. D., Inogés, S., Landecho, M. F., Gil-Alzugaray, B., Pérez, C., Botta, C., Zabaleta, A., et al. (2020) · Haematologica · doi:10.3324/haematol.2020.269878 · Cited by 17
SARS-CoV-2 Host Receptor ACE2 Protein Expression Atlas in Human Gastrointestinal Tract
An, X., Lin, W., Liu, H., Zhong, W., Zhang, X., Zhu, Y., Wang, X., Li, J., & Sheng, Q. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.659809 · Cited by 17
Lazarus, G., Budiman, R. A., & Rinaldi, I. (2021) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-021-02990-9 · Cited by 17
Krejčí, M., Pour, L., Adam, Z., Sandecká, V., Stork, M., Ševčı́ková, S., Krejčí, M., Knechtová, Z., & Král, Z. (2021) · Annals of Hematology · doi:10.1007/s00277-021-04594-w · Cited by 17
Huang, Y., Chen, S., Xiao, L., Qin, W., Li, L., Wang, Y., Ma, L., & Yuan, X. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.744659 · Cited by 16
Cellular therapies for the treatment and prevention of SARS-CoV-2 infection
Conway, S. R., Keller, M. D., & Bollard, C. M. (2022) · Blood · doi:10.1182/blood.2021012249 · Cited by 17
Dinkel, A., Goerling, U., Hönig, K., Karger, A., Maatouk, I., Petermann‐Meyer, A., Senf, B., Woellert, K., Wünsch, A., Zimmermann, T., et al. (2021) · Psycho-Oncology · doi:10.1002/pon.5759 · Cited by 16
Pinto, C., Berselli, A., Mangone, L., Damato, A., Iachetta, F., Foracchia, M., Zanelli, F., Gervasi, E., Romagnani, A., Prati, G., et al. (2020) · Biology · doi:10.3390/biology9080181 · Cited by 16
Rodríguez-Freixinós, V., Capdevila, J., Pavel, M. E., Thawer, A., Baudin, É., O’Toole, D., Herrmann, K., Welin, S., Grozinsky‐Glasberg, S., de Herder, W. W., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.11.037 · Cited by 16
Sobrado, L. F., Nahas, C. S. R., Marques, C. F. S., Cotti, G. C. D. C., Imperiale, A. R., Averbach, P., Júnior, J. D. D. M., Horvat, N. D. S. M. R., Ribeiro, U., Cecconello, I., et al. (2021) · Clinics · doi:10.6061/clinics/2021/e2507 · Cited by 16
Lemos, A., Silva, G. R., Gimba, E. R. P., & Matos, A. D. R. (2021) · Thoracic Cancer · doi:10.1111/1759-7714.14067 · Cited by 18
Patterns of Prostate-Specific Antigen Testing and Prostate Biopsies During the COVID-19 Pandemic
Kaufman, H. W., Chen, Z., Niles, J. K., Radcliff, J. S., & Fesko, Y. A. (2021) · JCO Clinical Cancer Informatics · doi:10.1200/cci.21.00074 · Cited by 16
Self-citationFreeman, V., Hughes, S., Carle, C., Campbell, D. J., Egger, S. J., Hui, H., Yap, S., Deandrea, S., Caruana, M., Onyeka, T. C., et al. (2022) · Journal of Cancer Policy · doi:10.1016/j.jcpo.2022.100340 · Cited by 16
Temena, M. A., & Acar, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-15911-2 · Cited by 17
Zhao, J., Han, X., Miller, K. D., Zheng, Z., Nogueira, L., Islami, F., Jemal, A., & Yabroff, K. R. (2023) · JCO Oncology Practice · doi:10.1200/op.22.00522 · Cited by 16
Survival in pediatric patients with cancer during the COVID-19 pandemic: scoping systematic review
Dorantes-Acosta, E. M., Ávila-Montiel, D., Klünder‐Klünder, M., Juárez‐Villegas, L., & Márquez-González, H. (2020) · Boletín Médico del Hospital Infantil de México · doi:10.24875/bmhim.20000174 · Cited by 12
Zhang, B., Yu, Y., Hubert, S. M., Zhang, Y., Lu, J., Liu, S., Xie, F., Zhao, L., Lei, X., Deng, W., et al. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.576994 · Cited by 15
Self-citationFactors associated with increased mortality in hospitalized COVID-19 patients
Shah, C., Grando, D. J., Rainess, R. A., Ayad, L., Gobran, E., Benson, P., Neblett, M. T., & Nookala, V. (2020) · Annals of Medicine and Surgery · doi:10.1016/j.amsu.2020.10.071 · Cited by 16
Kathuria‐Prakash, N., Mosaferi, T., Xie, M., Antrim, L. J., Angell, T. E., In, G. K., Su, M. A., & Lechner, M. G. (2021) · Endocrine Practice · doi:10.1016/j.eprac.2020.12.013 · Cited by 16
Psychological distress and moral injury to oncologists and their patients during COVID-19 pandemic
Rashid, S., Reeder, C., Sahu, S., & Rashid, S. (2021) · Current Psychology · doi:10.1007/s12144-021-02128-1 · Cited by 16
Gómez-Centurión, I. A., Oarbeascoa, G., Garcı́a, M. C., Fresneña, M. C. L., Carreño, M. J. M., Escudero‐Vilaplana, V., González-Haba, E., Bailén, R., Dorado, N., Salcedo, L. M. J., et al. (2021) · International Journal of Hematology · doi:10.1007/s12185-021-03219-2 · Cited by 16
Hyperglycosylated spike of SARS-CoV-2 gamma variant induces breast cancer metastasis.
Huang, H., Liao, C., Wang, S., Lee, I., Lee, T.-A., Hsu, J.-M., Kuo, C., Wang, J., Hsieh, W.-C., Chang, S., et al. (2021) · Europe PMC (PubMed Central) · Cited by 16
Dananché, C., Elias, C., Hénaff, L., Amour, S., Kuczewski, E., Gustin, M., Escuret, V., Saadatian‐Elahi, M., & Vanhems, P. (2022) · PLoS ONE · doi:10.1371/journal.pone.0261428 · Cited by 16
Chang, P. J., & Asher, A. (2021) · Physical Medicine and Rehabilitation Clinics of North America · doi:10.1016/j.pmr.2020.12.001 · Cited by 16
Abdulrahman, A., Mohamed, M. W., Alammadi, F., Almosawi, Z. S. A., Alsherooqi, R., Abduljalil, M., Kumar, N., & AlQahtani, M. (2021) · eJHaem · doi:10.1002/jha2.170 · Cited by 16
Safety of lung cancer surgery during COVID-19 in a pandemic epicenter
Villena‐Vargas, J., Lutton, E. M., Mynard, N., Nasar, A., Voza, F. A., Chow, O. S., Lee, B., Harrison, S. W., Stiles, B. M., Port, J. L., et al. (2022) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2021.11.092 · Cited by 16
Personalized cancer supportive care in COVID-19 era
Lyman, G. H., & Kuderer, N. M. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.05.003 · Cited by 16
Unique needs of childhood cancer survivors during the COVID-19 pandemic
Forster, V. J., & Schulte, F. (2020) · Supportive Care in Cancer · doi:10.1007/s00520-020-05824-z · Cited by 16
COVID‐19 und Auswirkungen auf dermatologische und allergologische Erkrankungen
Buhl, T., Beissert, S., Gaffal, E., Goebeler, M., Hertl, M., Mauch, C., Reich, K., Schmidt, E., Schön, M. P., Sticherling, M., et al. (2020) · JDDG Journal der Deutschen Dermatologischen Gesellschaft · doi:10.1111/ddg.14195_g · Cited by 15
Roshkovan, L., Chatterjee, N. R., Galperin-Aizenberg, M., Gupta, N. K., Shah, R. M., Barbosa, E. M., Simpson, S. A., Cook, T. S., Nachiappan, A. C., Knollmann, F. D., et al. (2020) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202006-600fr · Cited by 16
Jeon, D., Son, M., & Choi, J. (2020) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2020.486 · Cited by 15
Ladoire, S., Goussot, V., Redersdorff, E., Cueff, A., Ballot, E., Truntzer, C., Ayati, S., Bengrine-Lefèvre, L., Bremaud, N., Coudert, B. P., et al. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.02.027 · Cited by 15
Esperança‐Martins, M., Gonçalves, L., de Pinho, I. S., Gomes, A., Serrano, M., Blankenhaus, B., Figueiredo‐Campos, P., Catarina-Marques, A., Castro-Barbosa, A., Cardoso, A., et al. (2021) · The Oncologist · doi:10.1002/onco.13828 · Cited by 15
Teuscher, M., Diehl, K., Schaarschmidt, M., Weilandt, J., Sasama, B., Ohletz, J., Könnecke, A., Harth, W., Hillen, U., & Peitsch, W. K. (2021) · European Journal of Dermatology · doi:10.1684/ejd.2021.4098 · Cited by 15
Thyroid Cancer and COVID-19: Prospects for Therapeutic Approaches and Drug Development
Qu, N., Hui, Z., Shen, Z., Kan, C., Hou, N., Sun, X., & Han, F. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.873027 · Cited by 15
COVID‐19 effect on patients with noncommunicable diseases: A narrative review
Al-Qudimat, A. R., Darwish, M. B. A., Elaarag, M., Al‐Zoubi, R. M., Rejeb, M. A., Ojha, L. K., Nashwan, A. J., Alshunag, T., Turk-Adawi, K. I., Omri, A. E., et al. (2022) · Health Science Reports · doi:10.1002/hsr2.995 · Cited by 14
A global effort to understand the riddles of COVID-19 and cancer
Subbiah, V. (2020) · Nature Cancer · doi:10.1038/s43018-020-00129-w · Cited by 15
Treatment of Acute Leukemia During COVID-19: Focused Review of Evidence
Singh, S., Singh, J., Paul, D., & Jain, K. (2021) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2021.01.004 · Cited by 15
Mahmood, T. B., Chowdhury, A. S., Hossain, M. U., Hasan, M., Mizan, S., Aakil, M. M.-U.-I., & Hossan, M. I. (2021) · Current Research in Microbial Sciences · doi:10.1016/j.crmicr.2021.100022 · Cited by 15
Murris, F., Huchon, C., Zilberman, S., Dabi, Y., Phalippou, J., Canlorbe, G., Ballester, M., Gauthier, T., Avigdor, S., Cirier, J., et al. (2021) · Journal of Gynecology Obstetrics and Human Reproduction · doi:10.1016/j.jogoh.2021.102166 · Cited by 15
Stahl, M. F., Narendra, V. K., Jee, J., Derkach, A., Maloy, M., Geyer, M. B., Mato, A. R., Roeker, L. E., Tallman, M. S., Shah, G. L., et al. (2021) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2021.1885664 · Cited by 15
Clinical Impact of the COVID-19 Pandemic in Mexican Patients with Thoracic Malignancies
Arrieta, O. G., Lara‐Mejía, L., Bautista-González, E., Heredia, D., Turcott, J. G., Barrón, F., Ramos-Ramírez, M., Cabrera-Miranda, L. A., Padilla, M.-Á. S., Aguerrebere, M., et al. (2021) · The Oncologist · doi:10.1002/onco.13962 · Cited by 15
Impact of the COVID-19 pandemic on referral to and delivery of gynecologic oncology care
Bruce, S. F., Huysman, B. C., Bharucha, J., Massad, L. S., Mullen, M. M., Hagemann, A. R., Fuh, K. C., McCourt, C. K., Thaker, P. H., Khabele, D., et al. (2022) · Gynecologic Oncology Reports · doi:10.1016/j.gore.2022.100928 · Cited by 15
Liu, S., Zhao, Y., Feng, X., & Xu, H. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2103090 · Cited by 16
COVID-19 and Adult Acute Leukemia: Our Knowledge in Progress
Modemann, F., Ghandili, S., Schmiedel, S., Weisel, K. C., Bokemeyer, C., & Fiedler, W. (2022) · Cancers · doi:10.3390/cancers14153711 · Cited by 16
Zhuang, Z., Chen, Q., Zhong, X., Chen, H., Yu, R., & Tang, Y. (2022) · Journal of Ginseng Research · doi:10.1016/j.jgr.2022.09.006 · Cited by 15
Yang, Y., & Xu, G. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05922-w · Cited by 15
Does type of immunosupression influence the course of Covid-19 infection?
Razanamahery, J., Soumagne, T., Humbert, S., Brunel, A., Lepiller, Q., Daguindau, É., Mansi, L., Chirouze, C., & Bouiller, K. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.05.075 · Cited by 15
Impact of COVID-19 in gynaecological oncology care: a systematic rapid review
Nikolopoulos, M., Maheshwari, M. K., & Doumouchtsis, S. K. (2021) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-021-06295-1 · Cited by 16
Liu, W., Wu, Y., Yang, R., Chen, R., Huang, Y., Zhao, X., Xie, M., Li, Q., Wang, Q., & Chen, J. (2022) · Vaccines · doi:10.3390/vaccines10091530 · Cited by 14
Merli, M., Ferrarini, I., Merli, F., Busca, A., Mina, R., Falini, B., Bruna, R., Cairoli, R., Marchetti, M., Romano, A., et al. (2022) · Hematological Oncology · doi:10.1002/hon.3092 · Cited by 14
Assanto, G. M., Rocco, A. D., Malfona, F., Capriata, M., Giudice, I. D., Petrucci, L., Girardi, P., D’Elia, G. M., Martelli, M., Gentile, G., et al. (2022) · Hematological Oncology · doi:10.1002/hon.3113 · Cited by 14
Wu, M., Liu, S., Wang, C., Wu, Y., & Liu, J. (2023) · PLoS ONE · doi:10.1371/journal.pone.0291178 · Cited by 14
Self-citationGuo, W., Zheng, Y., & Feng, S. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1207225 · Cited by 15
Blot, F., Dumont, S., Vigouret-Viant, L., Vérotte, N., Rossignol, J., Rieutord, A., Fournier‐Bidoz, N., Jésus, A. D., Dauchy, S., Chardonnet, F., et al. (2020) · BMJ Supportive & Palliative Care · doi:10.1136/bmjspcare-2020-002504 · Cited by 14
Song, C., Dong, Z., Gong, H., Liu, X.-P., Dong, X., Wang, A., Chen, Y., Song, Q., & Hu, W. (2020) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-020-03420-6 · Cited by 14
Self-citationChagas, A. L., da Fonseca, L. G., Coelho, F. F., Saud, L. R. D. C., Abdala, E., Andraus, W., Fiore, L., Moreira, A. M., de Menezes, M. R., Carnevale, F. C., et al. (2020) · Clinics · doi:10.6061/clinics/2020/e2192 · Cited by 14
Oncologic immunomodulatory agents in patients with cancer and COVID-19
Jee, J., Stonestrom, A. J., Devlin, S. M., Nguyentran, T., Wills, B., Narendra, V. K., Foote, M. B., Lumish, M. A., Vardhana, S. A., Pastores, S. M., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-84137-5 · Cited by 14
Şahi̇n, M., Haymana, C., Demirci, İ., Taşçı, İ., Emral, R., Ünlütürk, U., Satman, İ., Demir, T., Çakal, E., Ata, N., et al. (2021) · Clinical Endocrinology · doi:10.1111/cen.14486 · Cited by 14
Prognostic and immunological value of ATP6AP1 in breast cancer: implications for SARS-CoV-2
Wang, J., Liu, Y., & Zhang, S. (2021) · Aging · doi:10.18632/aging.203229 · Cited by 14
Self-citationTargeting novel coronavirus SARS-CoV-2 spike protein with phytoconstituents of Momordica charantia
Singh, S. K., Singh, S., & Singh, R. (2021) · Journal of Ovarian Research · doi:10.1186/s13048-021-00872-3 · Cited by 14
Ali, A., Mughal, H., Aḥmad, N., Babar, Q., Saeed, A., Khalid, W., Raza, H., & Liu, A. (2021) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2021.1991317 · Cited by 14
Haematological malignancies implications during the times of the COVID‑19 pandemic (Review)
Papakonstantinou, E., Dragoumani, K., Efthimiadou, Α., Palaiogeorgou, A. M., Pierouli, K., Mitsis, Τ., Chrousos, G. P., Bacopoulou, F., & Vlachakis, D. (2021) · Oncology Letters · doi:10.3892/ol.2021.13117 · Cited by 14
Winter, F. D., Hotterbeekx, A., Huizing, M. T., Konnova, A., Fransén, E., Jongers, B. ‘., Jairam, R. K., averbeke, V. V., Moons, P., Roelant, E., et al. (2021) · Cancers · doi:10.3390/cancers13225718 · Cited by 13
Shoji, K., Tsuzuki, S., Akiyama, T., Matsunaga, N., Asai, Y., Suzuki, S., Iwamoto, N., Funaki, T., Yamada, M., Ozawa, N., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac028 · Cited by 14
COVID-19 in Patients with Hematologic Malignancies: Outcomes and Options for Treatments
Martínez, J. C., Sica, R. A., Stockerl-Goldstein, K. E., & Rubinstein, S. M. (2022) · Acta Haematologica · doi:10.1159/000522436 · Cited by 14
Peoples, A. R., Oswald, L. B., Ose, J., Daniels, B., Himbert, C., Hathaway, C. A., Gigic, B., Kirchhoff, A. C., Lin, T., Grossman, D., et al. (2022) · The Journal of Rural Health · doi:10.1111/jrh.12648 · Cited by 12
Reimann, H., Kremer, A. N., Blumenberg, V., Schmidt, K. G., Aigner, M., Jacobs, B., Eisenhauer, N., Kämpf, A., Rösler, W., Kharboutli, S., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2022007806 · Cited by 15
Cancer Patients during COVID-19 Pandemic: A Mini-Review
Linjawi, M., Shakoor, H. I., Hilary, S., Ali, H. I., Dhaheri, A. S. A., Ismail, L. C., Apostolopoulos, V., & Stojanovska, L. (2023) · Healthcare · doi:10.3390/healthcare11020248 · Cited by 14
Dipasquale, A., Persico, P., Lorenzi, E., Rahal, D., Santoro, A., & Simonelli, M. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2020-001870 · Cited by 15
Thyroid cancer and COVID-19: experience at one single thyroid disease referral center
Prete, A., Falcone, M., Bottici, V., Giani, C., Tiseo, G., Agate, L., Matrone, A., Cappagli, V., Valerio, L., Lorusso, L., et al. (2021) · Endocrine · doi:10.1007/s12020-021-02650-z · Cited by 14
Martin, S., Kaeuffer, C., Leyendecker, P., Tuzin, N., Tazi, Y., Schaff-Wendling, F., Kleinheny, T., Husson-Wetzel, S., Pamart, G., Limacher, J., et al. (2021) · The Oncologist · doi:10.1002/onco.13831 · Cited by 14
COVID-19 and breast cancer: may the microbiome be the issue?
Lasagna, A., Zuccaro, V., Ferraris, E., Corbella, M., Bruno, R., & Pedrazzoli, P. (2020) · Future Oncology · doi:10.2217/fon-2020-0764 · Cited by 14
Radcliffe, E., Khan, A., Wright, D. N. M., Berman, R. B., Demain, S. H., Foster, C. L., Restorick‐Banks, S., Richardson, A. M., Wagland, R., & Calman, L. A. (2021) · Palliative Medicine · doi:10.1177/02692163211049497 · Cited by 13
Challenges Related to Health Care for Iranian Women with Breast Cancer During the COVID-19 Pandemic
Atashi, V., Mohammadi, S., Salehi, Z., Shafiei, Z., Savabi-Esfahani, M., & Salehi, K. (2023) · Asian Journal of Social Health and Behavior · doi:10.4103/shb.shb_205_22 · Cited by 13
Lee, S. H., Lim, A. R., Kim, M. J., Choi, Y. J., Kim, J. W., Park, K. H., Shin, S. W., & Kim, Y. H. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.06.021 · Cited by 13
Caring for cancer patients in the Covid pandemic: choosing between the devil and deep sea
Chakraborty, M., & Pandey, M. (2020) · World Journal of Surgical Oncology · doi:10.1186/s12957-020-02002-7 · Cited by 13
Adverse events associated with potential drugs for COVID-19: a case study from real-world data
Jing, Y., Diao, L., & Han, L. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa234 · Cited by 12
Pala, L., Conforti, F., Cocorocchio, E., Ferrucci, P. F., Pas, M. T. D., Stucchi, S., Repetto, M., Saponara, M., & Queirolo, P. (2020) · Cancer Investigation · doi:10.1080/07357907.2020.1844893 · Cited by 13
Somashekhar, S. P., Acharya, R. P., Saklani, A. P., Parikh, D. G., Jagdishwar Goud, G., Dixit, J., Gopinath, K. S., Vijayakumar, M., Bhojwani, R., Nayak, S. P., et al. (2020) · Indian Journal of Surgical Oncology · doi:10.1007/s13193-020-01254-9 · Cited by 13
Kodama, T., Obinata, H., Mori, H., Murakami, W., Suyama, Y., Sasaki, H., Kouzaki, Y., Kawano, S., Kawana, A., & Mimura, S. (2020) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2020.12.009 · Cited by 13
Risk Factors of COVID-19 Patients
Ouchetto, O., & Bourhanbour, A. D. (2021) · Disaster Medicine and Public Health Preparedness · doi:10.1017/dmp.2021.7 · Cited by 13
COVID-19 and cancer: A comparative case series
Mousavi, S. A., Rostami, T., Kiumarsi, A., Rad, S., Rostami, M., Motamedi, F., Gandomi‐Mohammadabadi, A., & Mirhosseini, A. (2021) · Cancer Treatment and Research Communications · doi:10.1016/j.ctarc.2021.100339 · Cited by 13
Comparison of COVID-19 and Lung Cancer via Reactive Oxygen Species Signaling
Zhu, Z., Zheng, Z., & Liu, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.708263 · Cited by 13
Salomé, B., & Horowitz, A. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0613 · Cited by 13
Gupta, A., Desai, N., Sanjeev, Chauhan, P., Nityanand, S., Hashim, Z., & Gupta, M. (2021) · Annals of Hematology · doi:10.1007/s00277-021-04644-3 · Cited by 13
Ahmad, W., & Shabbiri, K. (2022) · The Egyptian Journal of Internal Medicine · doi:10.1186/s43162-021-00092-7 · Cited by 13
Global Effect of COVID-19 Pandemic on Cancer Patients and its Treatment: A Systematic Review
Ali, M., Wani, S. U. D., Masoodi, M. H., Khan, N. A., Shivakumar, H. G., Osmani, R. A. M., & Khan, K. A. (2022) · Clinical Complementary Medicine and Pharmacology · doi:10.1016/j.ccmp.2022.100041 · Cited by 14
Metadata
- Authors
- Dai, M., Liu, D., Liu, M., Zhou, F., Li, G., Chen, Z., Zhang, Z., You, H., Wu, M., Zheng, Q., Xiong, Y., Xiong, H., Wang, C., Chen, C., Xiong, F., Zhang, Y., Peng, Y., Ge, S., Zhen, B., Yu, T., Wang, L., Wang, H., Liu, Y., Chen, Y., Mei, J., Gao, X., Li, Z., Gan, L., He, C., Li, Z., Shi, Y., Qi, Y., Yang, J., Tenen, D. G., Chai, L., Mucci, L. A., Santillana, M., & Cai, H.
- Affiliations
- Zhongnan Hospital of Wuhan University (CN)
- Boston Children's Hospital (US)
- Brigham and Women's Hospital (US)
- Wuhan Union Hospital (CN)
- Central Hospital of Wuhan (CN)
- Huanggang Central Hospital (CN)
- Guangzhou Medical University (CN)
- Tongji Hospital (CN)
- 16Department of Radiology, Hubei Cancer Hospital, Wuhan, Hubei, China.
- Hubei Cancer Hospital (CN)
- Renmin Hospital of Wuhan University (CN)
- 19Department of Oncology, Wuhan Puren Hospital, Wuhan, Hubei, China.
- Xianning Central Hospital (CN)
- The Central Hospital of Xiao gan (CN)
- 22Department of Obstetrics and Gynecology, The People's Hospital of Huangmei, Huangmei, Hubei, China.
- Hubei University of Medicine (CN)
- Harvard University (US)
- Corresponding author
- Liu, Miao
- Santillana, Mauricio
- Cai, Hongbing
- ORCID
- Venue
- Cancer Discovery
- Published
- 2020-06-01
- Volume
- 10
- Issue
- 6
- Pages
- 783-791
- ISSN
- 2159-8274 (ISSN-L)
- 2159-8290
- PMC
- PMC7309152
- OpenAlex
- W3015599879
- Cited by
- 1,589
- References
- 27
- Citations by year
- 2026: 16 · 2025: 55 · 2024: 90 · 2023: 218 · 2022: 354 · 2021: 494 · 2020: 356
- FWCI
- 128.41
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cancer Discovery (publishedVersion)
- SSRN Electronic Journal (acceptedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (8197103302/H16)
- Singapore Ministry of Health's National Medical Research Council (MOH-STaR18nov-0002)
- NIH NHLBI (P01HL095489)
- Xiu Research Fund
- Institutional Ethics Board of Zhongnan Hospital of Wuhan University (2020029)
- Topics
- Health Sciences › Medicine › Oncology › COVID-19 and healthcare impacts
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Health Sciences › Medicine › Obstetrics and Gynecology › COVID-19 Impact on Reproduction
- Keywords
- COVID-19 pandemic, SARS-CoV-2, cancer patients, disease severity, hematologic malignancies, lung cancer, metastatic cancer, radiotherapy, infection susceptibility
- MeSH terms
- Betacoronavirus, COVID-19, SARS-CoV-2, Aged, China, Disease Outbreaks, Female, Humans, Intensive Care Units, Male, Middle Aged, Neoplasms, Pneumonia, Viral, Respiration, Artificial, Cohort Studies, Coronavirus Infections, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
